A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Investigational new drugs 2012 Jun 30 (3): 1164-74.
Oh Do-Youn, Lee Keun Wook, Lee Kyung-Hee, Sohn Chang-Hak, Park Young Suk, Zang Dae Young, Ryoo Hun-Mo, Song Hong-Suk, Kim Jin-Soo, Kang Hye-Jin, Kim Bong-Seog, Bang Yung-J
Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy.
PloS one 2012 7 (10): e48350.
Zhang Ling, Gao Guanghui, Li Xuefei, Ren Shengxiang, Li Aiwu, Xu Jianfang, Zhang Jie, Zhou Caic